This study examined Sheehan Disability Scale (SDS) performance in binge eating disorder (BED) and explored relationships between SDS and BED outcomes using data from three placebo‐controlled lisdexamfetamine (LDX) studies (two short‐term, dose‐optimized studies and one double‐blind, randomized‐withdrawal study) in adults with Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM‐IV‐TR)–defined BED.

中文翻译：

---

使用 Sheehan 残疾量表评估 lisdexamfetamine 二甲磺酸盐治疗暴食症的临床试验中的功能残疾

本研究检查了 Sheehan 残疾量表 (SDS) 在暴食症 (BED) 中的表现，并使用来自三项安慰剂对照 lisdexamfetamine (LDX) 研究（两项短期剂量优化研究和一项双盲、随机退出研究）成人精神障碍诊断和统计手册，第四版，文本修订（DSM-IV-TR）定义的 BED。